NRXPNRX Pharmaceuticals, Inc.

Nasdaq nrxpharma.com


$ 2.02 $ 0.04 (1.94 %)    

Friday, 03-May-2024 15:59:50 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 2.1
$ 2.14
$ 0.00 x 0
$ 0.00 x 0
$ 2.02 - $ 2.34
$ 1.90 - $ 54.00
268,096
na
2.01M
$ 0.83
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-29-2024 12-31-2023 10-K
2 08-14-2023 06-30-2023 10-Q
3 05-15-2023 03-31-2023 10-Q
4 03-31-2023 12-31-2022 10-K
5 11-14-2022 09-30-2022 10-Q
6 08-15-2022 06-30-2022 10-Q
7 05-16-2022 03-31-2022 10-Q
8 03-31-2022 12-31-2021 10-K
9 11-15-2021 09-30-2021 10-Q
10 08-16-2021 06-30-2021 10-Q
11 05-21-2021 03-31-2021 10-Q
12 04-01-2021 12-31-2020 10-K
13 11-16-2020 09-30-2020 10-Q
14 08-14-2020 06-30-2020 10-Q
15 05-15-2020 03-31-2020 10-Q
16 03-30-2020 12-31-2019 10-K
17 11-14-2019 09-30-2019 10-Q
18 08-14-2019 06-30-2019 10-Q
19 05-15-2019 03-31-2019 10-Q
20 03-15-2019 12-31-2018 10-K
21 11-08-2018 09-30-2018 10-Q
22 08-08-2018 06-30-2018 10-Q
23 05-15-2018 03-31-2018 10-Q
24 03-23-2018 12-31-2017 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-is-nrx-pharmaceuticals-stock-falling-after-data-from-suicidal-bipolar-depression-study

NRX Pharmaceuticals announces Phase 2b/3 trial findings of NRX-101 vs. Lurasidone for Suicidal Bipolar Depression.

 dow-surges-over-100-points-dr-horton-posts-upbeat-earnings

U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 100 points on Thursday. Following the market...

 nrx-pharmaceuticals-receives-notice-from-nasdaq-that-the-company-has-demonstrated-compliance-with-the-bid-price-requirement

The Nasdaq Panel has determined to continue the listing of the Company's securities on The Nasdaq Stock Market and is closi...

 nrx-pharmaceuticals-inc-announces-pricing-of-2m-underwritten-public-offering-of-common-stock-at-a-public-offering-price-of-330-per-share

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), ("NRx Pharmaceuticals" or the "Company"), a clinical-stage biopharmace...

 why-alcoa-shares-are-trading-higher-here-are-20-stocks-moving-premarket

Shares of Alcoa Corporation (NYSE: AA) rose sharply in today’s pre-market trading after the company reported better-than-expec...

 nrx-pharmaceuticals-intends-to-offer-to-sell-shares-of-its-common-stock-in-public-offering-no-terms-disclosed

NRx Pharmaceuticals intends to use the net proceeds from the offering for working capital and general corporate purposes, inclu...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION